Effects of Fish Oil on Risk Factors for Cardiovascular Disease

References

• Abbey M., Clifton P., Kestin M., Belling B., Nestel P. Effect of fish oil on lipoproteins, lecithin: cholesterol acyltransferase and lipid transfer protein activity in humans. Arteriosclerosis 1990; 10: 85–94
   PubMedGoogle Scholar
• Ackman R. G. Nutritional composition of fats in seafoods. Progr Food Nutr Sci. 1989; 13: 161–241
   PubMedGoogle Scholar
• Albina J. A., Cui S., Mateo R. B., Reichner J. S. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150: 5080–5085
   PubMed Web of Science ®Google Scholar
• Andersen O., Nilsen D. T., Lyberg Beckman S., Holme I., Hjermann I. Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals. Acta Med Scand 1988; 223: 499–506
   PubMedGoogle Scholar
• Andreasen P. A., Georg B., Lund L. R., Riccio A., Stacey S. N. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrin 1990; 68: 1–19
   PubMed Web of Science ®Google Scholar
• Austen M. A. Plasma triglyceride and coronary heart disese. Arteriosclerosis Thromb 1991; 11: 2–14
   PubMedGoogle Scholar
• Austen M. A. Joint lipid risk factors and coronary heart disease. Circulation 1992; 85: 365–367
   PubMed Web of Science ®Google Scholar
• Bang H. O., Dyerberg J., Sinclair H. M. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 1980; 33: 2657–2661
   PubMed Web of Science ®Google Scholar
• Bang H. O., Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. Advances in Nutrition Research, H H Draper. Plenum, New York 1980; 3: 1–22
   Google Scholar
• Barcelli U., Glas-Greenwalt P., Pollak V. E. Enhancing effect of dietary supplementation with n-3 fatty acids on plasma fibrinolysis in normal subjects. Thromb Res 1985; 39: 307–312
   PubMed Web of Science ®Google Scholar
• Barker D. J.P. Fetal origins of coronary heart disese. Br Heart J 1993; 69: 195–196
   PubMedGoogle Scholar
• Bhatnagar D., Mackness M. I., Prais H., Haynes B., Morgan J., Durrington P. N. Effect of a new fish oil concentrate (K85) on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Congress abstracts. OsloNorway 1992, Abstr. 127
   Google Scholar
• Beil F. U., Terres W., Orgass M., Greten H. Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis 1991; 90: 95–97
   PubMed Web of Science ®Google Scholar
• Bjerve K. S. n-3 fatty acid deficiency in man. J Intern Med 225 suppl. 1989; 1: 171–175
   Google Scholar
• Bjørneboe A., Søyland E., Bjørneboe G-E., Rajka G., Drevon C. A. Effect of n-3 fatty acid supplement to patients with atopic dermatitis. J Intern Med 225, suppl. 1989; 1: 233–236
   Google Scholar
• Blok W. L., Vogels M. T.E., Curfs J. H.A.J., Eling W. M.C., Buurman W. A., van der Meer J. W.M. Dietary fish-oil supplementation in experimental gramnegative infection and in cerebral malaria in mice. J Infect Dis 1992; 165: 898–903
   PubMed Web of Science ®Google Scholar
• Blonk M. C., Bilo H. J.G., Nauta J. J.P., Popp-Snijders C., Mulder C., Donker A. J.M. Dose-response effects of fsih-oil supplements in healthy volunteers. Am J Clin Nutr 1990; 52: 120–127
   PubMed Web of Science ®Google Scholar
• Boberg M., Vessby B., Selinus I. Effects of dietary supplementation with n-6 and n-3 long chain polyunsaturated fatty acids on serum lipoprot-eins and platelet function in hypertriglyceridemic patients. Acta Med Scand 1986; 220: 153–160
   PubMedGoogle Scholar
• Borkman M., Storlien L. H., Pan D. A., Jenkins A. B., Chisholm D. J., Campbell L. V. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1991; 328: 238–244
   Web of Science ®Google Scholar
• Boulanger C., Schini V. B., Shimokawa H., Lüscher T. F., Vanhoutte P. M. Effect of chronic exposure to cod liver oil and ω-3 unsaturated fatty acids on endothelium-dependent relaxations. Fish and bloodvessel interactions, P. M. Vanhoutte, P Douse-Blazy. John Libbey Eurotext, Paris 1991; 89–97
   Google Scholar
• Brattström I. E., Israelsson B., Jeppsson J. O., Hultberg B. L. Folic acid - an innocous means to reduce plasma homocysteine. Scand J Clin Invest 1988; 48: 215–221
   PubMed Web of Science ®Google Scholar
• Brenner R. R. Factors influencing fatty acid chain elongation and desaturation. The role of fats in human nutrition, A. J. Vergroesen, M. Crawford. Academic Press. 1988; 45–79
   Google Scholar
• Brewer H. B., Rader D., Fojo S., Hoeg J. M. Frontiers in the analysis of HDL structure, function and metabolism. Disorders of HDL., L. A. Carlson. Eldred Smith-Gordon. 1990; 51–58
   Google Scholar
• Bryant J., Young B. C., Mehta P., Saldeen T. G.P., Mehta J. Dietary fish oil decreases superoxide radical generation without affecting nitric oxide synthase activity: a mechanism of vasorelaxation. J Am Coll Cardiol 1993; 21: 430 A, (abstract 819–2)
   Google Scholar
• Bønaa K. H., Bjerve K. S., Straume B., Gram I. T., Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study. N Engl J Med 1990; 322: 795–801
   PubMed Web of Science ®Google Scholar
• Burr M. L., Gilbert J. F., Holliday R. L. Effects of changes in fat, fish and fibre intake on death and myocardial reinfarction: Diet and reinfarction trial (DART). Lancet 1989; II: 757–761
   Google Scholar
• Carlson L. A., Böttiger L., Ahlfeldt P. Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 1979; 206: 351–360
   PubMedGoogle Scholar
• Carlson L. A., Hamsten A., Asplund A. Pronounced lowering of serum levels of lipoprotein Lp (a) in hyperlipidemic subjects treated with nicotinic acid. J Intern Med 1989; 226: 271–276
   PubMed Web of Science ®Google Scholar
• Chang H. R., Dulloo A. G., Vladoianu I. R., Piguet P. F., Arsenijevic D., Girardier L., Pechère J. C. Fish oil decreases natural resistance of mice to infection with Salmonella typhimurium. Metabolism 1992; 41: 1–2
   PubMed Web of Science ®Google Scholar
• Charnock J. S. Antiarrhytmic effects of fish oils. Health effects of ω-3 polyunsaturated fatty acids in seafoods, A. P. Simopoulos, R. R. Kifer, R. E. Martin, S. M. Barlow. World Rev Nutr Diet, Karger, Basel 1991; 66: 278–291
   Google Scholar
• Chester A. H., O'Neil G. S., Moncada S., Tadjkarimi S., Yacoub M. H. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990; 336: 897–900
   PubMed Web of Science ®Google Scholar
• Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149–1155
   PubMed Web of Science ®Google Scholar
• Collins R., Peto R., MacMahon S. Blood pressure, stroke, and coronary heart disease: part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiologic context. Lancet 1990; 355: 827–838
   Google Scholar
• Crawford M. A., Doyle W., Drury P., Chebremeskel K., Harbige L., Leyton J., Williams G. The food chain for n-6 and n-3 fatty acids with special reference to animal products. Dietary ω3 and ω6 fatty acids, C Galli, A P Simopoulos. Plenum Press, New York 1989; 5–19
   Google Scholar
• Cunnane S. C., Manku M. S., Horrobin D. F. Effect of vitamin B-6 defiency on essential fatty acid metabolism. Vitamin B-6: Its role in health and disease, R. D. Reynolds, J. E. Leklem. Alan R. Liss Inc., New York 1985; 447–451
   Google Scholar
• Cunnane S. C. What is the nutritional and clinical significance of α-linolenic acid in humans?. Essential fatty acids and eicosanoids, A. Sinclair, R. Gibson. American Oil Chemists Society, Champaign, Illinois 1992; 379–382
   Google Scholar
• Davey Smith G., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. Brit Med J 1993; 306: 1367–1373
   PubMedGoogle Scholar
• Davies H. R., Bridenstine R. T., Vesselinovitch D., Wissler R. W. Fish oil inhibits development of atherosclerosis in rhesus monkeys. Atherosclerosis 1987; 7: 441–449
   Google Scholar
• Davies M. J., Woolf N. Atherosclerosis: what is it and why does it occur?. Br Heart J 1993; 69: S3–S11, suppl.
   PubMedGoogle Scholar
• Dawson S., Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 1992; 95: 105–117
   PubMed Web of Science ®Google Scholar
• Dehmer G. J., Pompa J. J., Van de Berg E. K. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988; 319: 733–740
   PubMed Web of Science ®Google Scholar
• Dolecek T. A., Grandits G. Dietary polyunsaturated fatty acid and mort-ality in the multiple risk factor intervention trial (MRFIT). Health effects of ω-3 polyunsaturated fatty acids in seafoods, A. P. Simopoulos, R. R. Kiferm, R. E. Martin, S. M. Barlow. World Rev Nutr Diet, Karger, Basel 1991; 66: 205–217
   Google Scholar
• Dolecek T. A., Shaten J., Stamler J. Dietary ω-fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Omega-3 fatty acids. Metabolism and biological effects. Congress abstracts. Oslo, Norway 1992; 9, Abstr.
   Google Scholar
• Dormandy T. L. In praise of peroxidation. Lancet 1988; II: 1126–1128
   Google Scholar
• Drevon C. A. Marine oils and their effects. Nutr Rev 1992; 50: 38–45
   PubMed Web of Science ®Google Scholar
• Dwyer J. T. Assessment of dietary intake. Modern nutrition in health and disease, 7th ed., M. E. Shils, V. R. Young. Lea & Febiger, Philadelphia 1988; 887–905
   Google Scholar
• Dyerberg J., Bjerregaard P. Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. Proceedings of the AOCS short course on polyunsaturated fatty acids and eicosanoids, W. E.M. Lands. American Oil Chemists Society, Biloxi 1987; 2–8, Miss.
   Google Scholar
• Dyerberg J., Schmidt E. B. Modulation of atherothrombogenesis by n-3 polyunsaturated fatty acids. Essential fatty acids and eicosanoids, A. Sinclair, R. Gibson. American Oil Chemists Society, Champaign 1992; Ill: 293–296
   Google Scholar
• Edelberg J. M., Gonzales-Gronow M., Pizzo S. V. Lipoprotein (a) inhibition of plasminogen activation by tissue-type plasminogen activator. Thromb Res 1990; 57: 155–162
   PubMed Web of Science ®Google Scholar
• El Boustani S., Colette C., Monnier L., Descomps B., de Paulet Crastes A.C., Mendy F. Enteral absorption in man of eicosapentaenoic acid in different chemical forms. Lipids 1987; 22: 711–714
   PubMed Web of Science ®Google Scholar
• Emeis J. J., Van Houvlingen A. C., Van Den Hoogen C. M. A moderate fish intake increases plasminogen activator inhibitor type-1 in human volunteers. Blood 1989; 74: 233–237
   PubMed Web of Science ®Google Scholar
• Endres S., Ghorbani R., Kelley V. E., Georgilis K., Lonnemann G., Klempner Weber M.S.P.C., Schaefer E. J., Woolff S. M., Dinarello C. A. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265–271
   PubMed Web of Science ®Google Scholar
• Ernst E. Effects of n-3 fatty acids on blod rheology. J Intern Med 1989; 225: 129–132
   PubMed Web of Science ®Google Scholar
• Ernst E. The role of fibrinogen as a cardiovascular risk factor. Atherosclerosis 1993; 100: 1–12
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Wäg G., Puhl H. Lipid peroxidation and its role in atherosclerosis. Brit Med Bull 1993; 49: 566–576
   PubMed Web of Science ®Google Scholar
• Falk E. Why do plaques rupture?. Circulation 86, suppl. 1992; III: III-39–II-42
   Google Scholar
• Federal Register. Food labeling: Health claims and label statement: Omega-3 fatty acids and coronary heart disease. 56 no. 1991; 229: 60663–60689
   Google Scholar
• Fischer S., Weber P. C. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984; 307: 165–168
   PubMed Web of Science ®Google Scholar
• Fitzgerald G. A., Braden G., Fitzgerald D. J., Knapp H. R. Fish oils in cardiovascular disease. J Intern Med 225, suppl. 1989; 1: 25–29
   Google Scholar
• Fumeron F., Brigant L., Ollivier V., de Prost D., Driss F., Darcet P., Bard J. M., Parra H. J., Furchart J. C., Apfelbaum M. n-3 polyunsaturated fatty acids raise low-density lipoproteins, high density lipoprotein 2, and plasminogen-activator inhibitor in healthy young men. Am J Clin Nutr 1991; 54: 118–122
   PubMed Web of Science ®Google Scholar
• Förstermann U., Schmidt H., Pollock J. S., Sheng H., Mitchell J. A., Warner T. D., Nakane M., Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991; 42: 1849–1857
   PubMed Web of Science ®Google Scholar
• Gans R. O.B., Bilo H. J.G., Schouten J. A., Rawerda J. A. Fish oil and fibrinogen. Brit Med J 1988; 297: 978–979
   PubMedGoogle Scholar
• Gapinski J. P., Van Ruiswyk J. V., Heudebert G. R., Schectman G. S. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med 1993; 153: 1595–1601
   PubMedGoogle Scholar
• Gavish D., Azrolan N., Cundey K., Breslow J. L. Fish oil reduces plasma Lp(a) levels and affects postprandial association of apo(a) with triglyceride rich lipoproteins. Clin Res: abstract 250 1990
   Google Scholar
• Glauber H., Wallance P., Griver K., Brechtel G. Adverse effects of omega-3 fatty acids in noninsulin-dependent diabetes mellitus. Ann Intern Med 1988; 108: 663–668
   PubMed Web of Science ®Google Scholar
• Goodnight S. H., Fischer M., Fitzgerald G. A., Levine P. H. Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis. Chest 1989; 95: 19S–24S
   Web of Science ®Google Scholar
• Goodnight S. H. Fish oil: effects on atherogenesis and thrombosis. Curr Opin Lipidol 1990; 1: 334–340
   Google Scholar
• Granger D. L. Macrophage production of nitrogen oxides in host defence against microorganisms. Res Immunol 1991; 142: 570–572
   PubMedGoogle Scholar
• Granström E. Omega-3 polyunsaturated fatty acids: Biochemical actions. Marine foods, J. C. Somogyi, D. Hötzel. Bibl Nutr Dieta, Basel, Karger 1990; 87–94
   Google Scholar
• Grayston J. T. Chlamydia in atherosclerosis. Circulation 1993; 87: 408–409
   Web of Science ®Google Scholar
• Grundy S. M., Vega G. L. Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implication for treatment. Arch Intern Med 1992; 152: 28–34
   PubMed Web of Science ®Google Scholar
• Grønn M. Metabolism of n-3 fatty acids. Studies of β-oxidation and desaturation in isolated hepatocytes and human fibroblasts. Thesis. Oslo 1992
   Google Scholar
• Gustafson A., Elmfeldt D., Wilhelmsen L., Tibblin G. Serum lipids and lipoproteins in men after myocardial infarction compared with representative population sample. Circulation 1972; 46: 709–716
   PubMed Web of Science ®Google Scholar
• Göttlicher M., Widmark E., Li Q., Gustafsson J. Å. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci. 1992; 89: 4653–4657
   PubMed Web of Science ®Google Scholar
• Haglund O., Wallin R., Luostarinen R., Saldeen T. Effects of a new fluid fish oil concentrate, ESKIMO-3, on triglycerides, cholesterol, fibrinogen and blood pressure. J Intern Med 1990; 227: 347–353
   PubMed Web of Science ®Google Scholar
• Haglund O., Luostarinen R., Wallin R., Saldeen T. Effects of fish oil on triglycerides, cholesterol, lipoprotein (a), atherogenic index and fibrinogen. Influence of degree of purification of the oil. Nutr Res 1992; 12: 455–468
   Web of Science ®Google Scholar
• Haglund O., Luostarinen R., Wallin R., Wibell L., Saldeen T. The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondi-aldehyde in humans supplemented with vitamin E. J Nutr 1991; 121: 165–169
   PubMed Web of Science ®Google Scholar
• Haglund O., Hamfelt A., Hambraeus L., Saldeen T. Effects of fish oil supplemented with pyridoxine and folic acid on homocysteine, atherogenic index, fibrinogen and plasminogen activator inhibitor-1 in man. Nutr Res 1993, in press
   Web of Science ®Google Scholar
• Haglund O., Wallin R., Wretling S., Hultberg B., Saldeen T. Effects of fish oil alone and combined with long chain (n-6) fatty acids on some coronary risk factors in man. J Nutr Biochem 1993, in press
   Google Scholar
• Haglund O., Mehta J. L., Saldeen T. Effects of fish oil on some parameters of fibrinolysis and lipoprotein (a) in man. Am J Cardiol 1993, in press
   Web of Science ®Google Scholar
• Haglund O., Dutertre Y., Saldeen T. Eicosapentaenoic acid decreases nitric oxide activity and increases cell viability in a stimulated macro-phage cell line. Possible implications for the involvement of (n-3) fatty acids in the protection against cardiovascular and inflammatory diseases, Manuscript
   Google Scholar
• Hagve T. A., Christensen E., Gronn M., Christophersen B. O. Regulation of the metabolism of polyunsaturated fatty acids. Scand J Clin Lab Invest 48, suppl. 1988; 191: 33–46
   PubMedGoogle Scholar
• Hamsten A., Wiman B., de Faire U., Blombäck M. Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–1563
   PubMed Web of Science ®Google Scholar
• Hamsten A. Hypertriglyceridemia, triglyceride-rich lipoproteins and coronary heart disease. In: Baillière's Clinical Endocrinology And Metabolism: Lipid and Lipoprotein Disorders 1990; 4: 895–922
   PubMed Web of Science ®Google Scholar
• Hamsten A. The hemostatic system and coronary heart disease. Thromb Res 1993; 70: 1–38
   PubMed Web of Science ®Google Scholar
• Harris W. S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989; 30: 785–807
   PubMed Web of Science ®Google Scholar
• Heller R. F., Chinn S., Tunstall-Pedoe H. D., Rose G. How well can we predict coronary heart disease?. Br Med J 1984; 288: 1409–1411
   PubMed Web of Science ®Google Scholar
• Herrmann W., Biermann J., Lindhofer H. G., Kostner G. Beeinflussung des atherogenen Risikofaktors Lp(a) durch supplementäre Fischölaufnahme bei Patienten mit moderatem physischen Training. Med Klin 1989; 84: 429–433
   Google Scholar
• Hibbs J. B., Taintor R. R., Vavrin Z., Rachlin E. M. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157: 87–94
   PubMed Web of Science ®Google Scholar
• Hibbs J. B. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res Immunol 1991; 142: 565–569
   PubMedGoogle Scholar
• Hills M., Armitage P. The two-period cross-over clinical trial. Br J Pharmac 1979; 8: 7–20
   Web of Science ®Google Scholar
• Hirai A., Terano T., Tamura Y., Yoshida S. Eicosapentaenoic acid and adult diseases in Japan: epidemiological and clinical aspects. J Intern Med 225, suppl. 1989; 1: 69–75
   Google Scholar
• Hogg B., Darley-Usmar V. M., Graham A., Moncada S. Peroxynitrite and atherosclerosis. Biochem Soc Trans 1993; 21: 358–362
   PubMed Web of Science ®Google Scholar
• Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 1990; 82: 1916–1924
   PubMed Web of Science ®Google Scholar
• Hopkins P. N., Williams R. R. A survey of 246 suggested coronary risk factors. Atherosclerosis 1981; 40: 1–52
   PubMed Web of Science ®Google Scholar
• Hornstra G. The significance of fish and fish oil enriched food for prevention and therapy of ischemic cardiovascular disease. The role of fats in human nutrition, 2nd ed., A. J. Vergroessen, M. Crawford. Academic Press, London 1989; 152–235
   Google Scholar
• Horrobin D. F., Manku M. S. Clinical biochemistry of essential fatty acids. Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine, D. F. Horrobin. Wiley-Liss, New York 1990; 21–53
   Google Scholar
• Huang Y. S., Nassar B. A. Modulation of tissue fatty acid composition, prostaglandin production and cholesterol levels by dietary manipulation of n-3 and n-6 essential fatty acid metabolites. Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine, D. F. Horrobin. Wiley-Liss, New York 1990; 21–53
   Google Scholar
• Hughes G. S., Ringer T. V., Watts K. C., DeLoof M. J., Framcom S. F., Spillers C. R. Fish oil produces an atherogenic lipid profile in hypertensive men. Atherosclerosis 1990; 84: 229–237
   PubMed Web of Science ®Google Scholar
• Högman M., Frostell C., Arnberg H., Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet 1993; 341: 1664
   PubMed Web of Science ®Google Scholar
• Høstmark A. T., Bjerkedal T., Kierulf P., Flaten H., Ulshagen K. Fish oil and plasma fibrinogen. Br Med J 1988; 297: 180–181
   PubMed Web of Science ®Google Scholar
• Jessup W., Dean R. Autoinhibition of murine macrophage-mediated oxidation of low-density lipoprotein by nitric oxide synthesis. Atherosclerosis 1993; 101: 145–155
   PubMed Web of Science ®Google Scholar
• Jürgens G., El-Saadani M., Streigl G., Esterbauer H. LDL modified by endogenous lipid peroxidation products. Modified lipoproteins. 8th Internatonal symposium on atherosclerosis, D. Steinberg. Venice 1988; 13–20
   Google Scholar
• Karmali R. A. n-3 fatty acids and cancer. J Intern Med 225, suppl. 1989; 1: 197–200
   Google Scholar
• Knapp H. R. Hypotensive effects of w-3 fatty acids: Mechanistic aspects. Health effects of ω-3 polyunsaturated fatty acids in seafoods. World Rev Nutr Diet, Karger, Basel 1991; 66: 313–328
   Google Scholar
• Kolb H., Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 1992; 13: 157–160
   PubMedGoogle Scholar
• Kremer J. M., Jubiz W., Michalek A. Fish-oil supplementation in active rheumatoid arthritis. Ann Intern Med 1987; 106: 497–503
   PubMed Web of Science ®Google Scholar
• Kromann N., Green A. Epidemiological studies in the Upernavik District, Greenland: incidence of some chronic diseases 1959–1974. Acta Med Scand 1980; 208: 401–406
   PubMed Web of Science ®Google Scholar
• Kromhaut D., Bosschieter E. B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205–1209
   PubMed Web of Science ®Google Scholar
• Landymore R. W., MacAulay M., Sheridan B., Cameron C. Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. Ann Thorac Surg 1986; 41: 54–57
   PubMed Web of Science ®Google Scholar
• Lawson D. L., Mehta J. L., Saldeen K., Mehta P., Saldeen T. G.P. Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids 1991; 4: 217–223
   PubMedGoogle Scholar
• Leaf A., Weber P. C. A new era for science in nutrition. Am J Clin Nutr 1987; 45: 1048–1053
   PubMed Web of Science ®Google Scholar
• Leaf A. Health claims: Omega-3 fatty acids and cardiovascular disease. Nutr Rev 1992; 50: 150–154
   PubMed Web of Science ®Google Scholar
• Lee T. H., Hoover R. L., Williams J. D., Sperling R. I., Ravalese I J., II, Spur B. W., Robinson D. R., Corey E. J., Lewis R. A., Austen K. F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985; 312: 1217–1224
   PubMed Web of Science ®Google Scholar
• Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S.V., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626–632
   PubMed Web of Science ®Google Scholar
• Loscalzo J. Lipoprotein (a). A unique risk factor for atherothrombotic disease. Arteriosclerosis 1990; 10: 672–679
   PubMedGoogle Scholar
• Martin J. H.J., Edwards S. W. Changes in the mechanisms of monocyte/macrophage-mediated cytotoxity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxity, wheras reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J Immunoll50 1993; 3478–3486
   PubMed Web of Science ®Google Scholar
• Mascioli E. A., Yoshie I., Trimbo S., Leader L., Bistrian B. R., Blackburn G L. Endotoxin challenge after menhaden oil diet; effects on survival of guinea pigs. Am J Clin Nutr 1989; 49: 277–282
   PubMed Web of Science ®Google Scholar
• McCully K. S. Homocysteine theory of arteriosclerosis; development and current status. Atherosclerosis Rev 1983; 11: 157–246
   Google Scholar
• McCully K. S., Olszewski A. J., Vezeridis M. P. Homocysteine metabolism in atherogenesis: effect of the homocysteine thiolactonyl derivatives, thioretinaco and thioretinamide. Atherosclerosis 1990; 83: 197–206
   PubMed Web of Science ®Google Scholar
• Mehta J., Lawson D., Saldeen T. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J 1988; 116: 1201–1206
   PubMed Web of Science ®Google Scholar
• Mensink R P. Effect of the individual saturated fatty acids on serum lipids and lipoprotein concentrations. Am J Clin Nutr 57, suppl. 1993; 711S–714S
   Google Scholar
• Moncada A., Palmer R. M.J., Higgs E. A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109–142
   PubMed Web of Science ®Google Scholar
• Moncada S., Martin J. F., Higgs A. Symposium on regression of atherosclerosis. Eur J Clin Invest 1993; 23: 385–398
   PubMed Web of Science ®Google Scholar
• Morris M. C., Taylor J. O., Stampfer M. J., Rosner B., Sacks F. M. The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized cross-over trial. Am J Clin Nutr 1993; 57: 59–64
   PubMed Web of Science ®Google Scholar
• Morris M. C., Sacks F., Rosner B. Does fish oil lower blood pressue? A meta-analysis of controlled trials. Circulation 1993; 88: 523–533
   PubMed Web of Science ®Google Scholar
• Mudd S. H., Levy H. L., Skovby F. Disorders of transsulfuration. The metabolic basis of inherited disease, C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle. Alan Liss, Inc, New York 1989; 482–519
   Google Scholar
• Müllertz A., Hølmer G., Grøndahl-Hansen J. Increased concentration of plasminogen activator inhibitor type-1 in plasma after intake of fish oil. Fibrinolysis 4, suppl. 1990; 2: 86–88
   Google Scholar
• Møller J. M., Svaneborg N., Lervang H. H., Vanning K., Madsen P., Dyerberg J., Schmidt E. B. The acute effect of a single very high dose of n-3 fatty acids on coagulation and fibrinolysis. Thromb Res 1992; 67: 569–577
   PubMed Web of Science ®Google Scholar
• Nathan D. M. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676–1685
   PubMed Web of Science ®Google Scholar
• Nelson G. J., Ackman R. G. Absorption and transport of fat in mammals with emphasis on n-3 polyunsaturated fatty acids. Lipids 1988; 23: 1005–1014
   PubMed Web of Science ®Google Scholar
• Nenseter M. S., Rustan A. C., Lund-Katz S., Søyland E., Mælandsmo G., Phillips M. C., Drevon C. A. Effect of dietary supplementation with n-3 polyunsaturated fatty acid on physical properties and metabolism of low-density lipoprotein in humans. Arteriosclerosis Thromb 1992; 12: 369–379
   PubMedGoogle Scholar
• Nestel P. J. Effect of fish oils on plasma lipids, atherosclerosis and the heart. Essential fatty acids and eicosanoids, A. Sinclair, R. Gibson. AOCS, Champaign, Ill 1993; 248–251
   Google Scholar
• Nettleton J. A. Are n-3 fatty acids essential nutrients for fetal and infant development? J Am Diet Ass 1993; 93: 58–64
   PubMed Web of Science ®Google Scholar
• Newman W. P., Middaugh J. P., Propst M. T., Rogers D. R. Atherosclerosis in Alaska Natives and non-natives. Lancet 1993; 341: 1056–1057
   PubMed Web of Science ®Google Scholar
• Nilsson I. M., Olow B. Determination of fibrinogen and fibrinolytic activity. Throb Diath Haemorrh 1962; 8: 297–310
   PubMedGoogle Scholar
• Nilsson I. M., Ljungner H., Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Brit Med J 1985; 290: 1453–1456
   PubMedGoogle Scholar
• Nordøy A., Barstad L., Connor W., Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglyce-rides by humans. Am J Clin Nutr 1991; 53: 1185–1190
   PubMed Web of Science ®Google Scholar
• Nunez E. A. Free fatty acids as modulators of the steroid hormone message. Prost Leuk Essent Fatty Acids 1993; 48: 63–70
   PubMed Web of Science ®Google Scholar
• Olszewski A. J., McCully K. S. Homocysteine content of lipoproteins in hypercholesterolemia. Atherosclerosis 1991; 88: 61–68
   PubMed Web of Science ®Google Scholar
• Olszewski A. J., McCully K. S. Fish oil decreases serum homocysteine in hyperlipemic men. Coron Art Dis 1993; 4: 53–60
   PubMed Web of Science ®Google Scholar
• Palmblad J., Gyllenhammar H. Effect of dietary lipids on immunity and inflammation. APMIS 1988; 96: 571–583
   PubMed Web of Science ®Google Scholar
• Panza J. A., Quyyumi A. A., Brush J. E., Epstein S. E. Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27
   PubMed Web of Science ®Google Scholar
• Parks E. J., Tinker L. F., Behr S. R., Scheeman B. O., Davis P. A. Fish oil supplementation changes LDL particle size in hypertriglyceridemics. Faseb J 1993; 7, abstract A870
   Web of Science ®Google Scholar
• Parks J. S., Bullock B. C. Effect of fish oil versus lard diets on the chemical and physical properties of low density lipoproteins of nonhuman primates. J Clin Invest 1987; 28: 173–182
   Google Scholar
• Phillipson B. E., Rothrock D. W., Connor W. E., Harris W. S., Illingworth D. R. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985; 312: 1210–1216
   PubMed Web of Science ®Google Scholar
• Pike M. C. Antiinflammatory effects of dietary lipid modification. J Rheumatol 1989; 16: 718–720
   PubMed Web of Science ®Google Scholar
• Popp-Snijders C., Schouten J. A., Heine R. J., van der Meer J., van der Veen E. A. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res 1987; 4: 141–147
   PubMedGoogle Scholar
• Prins M. H., Hirsh J. A. A critical review of the relationship between impaired fibrinolysis and myocardial infarction. Am Heart J 1991; 122: 545–551
   PubMed Web of Science ®Google Scholar
• Pritchard G. A., Jones D. L., Mansel R. E. Lipids in breast carcinogenesis. Br J Surg 1989; 76: 1069–1073
   PubMed Web of Science ®Google Scholar
• Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Ridker P. M., Vaughan D. E., Stampfer M. J., Manson J. E., Hennekens C. H. A prospective study of plasminogen activator inhibitor and the risk of future myocardial infarction. Circulation 1992; 86: 1–325, suppl.
   PubMedGoogle Scholar
• Ridker P. M., Vaughan D. E., Stampfer M. J., Manson J. E., Hennekens C. H. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165–1168
   PubMed Web of Science ®Google Scholar
• Robinson D. R., Xu L. L., Tateno S., Guo M., Colvin R. B. Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res 1993; 34: 1435–1444
   PubMed Web of Science ®Google Scholar
• Rodgers R. P.C., Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemostas 1990; 16: 1–20
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1992; 362: 801–809
   Web of Science ®Google Scholar
• Rustan A. C., Nossen J. Ø., Christiansen E. N., Drevon C. A. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res 1988; 29: 1417–1426
   PubMed Web of Science ®Google Scholar
• Sanders T. A.B. Influence of ω3 fatty acids on blood lipids. Health effects of ω3 polyunsaturated fatty acids in seafoods, A. P. Simopoulos, R. R. Kifer, R. E. Martin, S. M. Barlow. World Rev Nutr Diet. 1991; 66: 358–366
   Google Scholar
• Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 1993; 191: 503–508
   PubMed Web of Science ®Google Scholar
• Saynor R., Verel D., Gillott T. The long term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 1984; 50: 3–10
   PubMed Web of Science ®Google Scholar
• Saynor R., Gillott T. Changes in blood lipids and fibrinogen with a note of safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years. Lipids 1992; 27: 533–538
   PubMed Web of Science ®Google Scholar
• Schectman G., Kaul S., Cherayil G. D., Lee M., Kissebah A. Can the hypotriglyceridemic effect of fish oil concentrate be sustained?. Ann Intern Med 1989; 110: 346–352
   PubMed Web of Science ®Google Scholar
• Schmidt E. B., Kristensen S. D., Dyerberg J. The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery 1988; 15: 316–329
   PubMedGoogle Scholar
• Schmidt E. B., Sørensen P. J., Ernst S. D., Kristensen S. D., Pederson J. O., Dyerberg J. Studies on coagulation and fibrinolysis in Greenland eskimos. Thromb Res 1989; 56: 553–558
   PubMed Web of Science ®Google Scholar
• Schmidt E. B., Vanning K., Ernst E., Madsen F. P., Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost 1990; 63: 1–5
   PubMed Web of Science ®Google Scholar
• Schmidt E. B., Klausen I. C., Kristensen S. D. The effect of n-3 polyunsaturated fatty acids on Lp(a). Clin Chim Acta 1991; 198: 271–278
   PubMed Web of Science ®Google Scholar
• Schmidt E. B., Lervang H. H., Varming K., Madsen P., Dyerberg J. Long-term supplementation with n-3 fatty acids. I: Effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Invest 1992; 52: 221–228
   PubMed Web of Science ®Google Scholar
• Selhub J., Miller J. W. The pathogenesis of homocysteinemia: interuption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992; 55: 131–138
   PubMed Web of Science ®Google Scholar
• Siegbahn A., Odlind V., Hedner U. Coagulation and fibrinolysis during the normal menstrual cycle. Upsala J Med Sci. 1989; 94: 137–153
   PubMed Web of Science ®Google Scholar
• Silverman D. I., Reis G. J., Sacks F. M., Boucher T. M., Pasternak R. C. Usefulness of plasma phospholipid n-3 fatty acid levels in prediciting dietary fish intake in patients with coronary artery disease. Am J Cardiol 1990; 66: 860–862
   PubMed Web of Science ®Google Scholar
• Simopoulos A. P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438–463
   PubMed Web of Science ®Google Scholar
• Singer P., Wirth M., Berger I. A possible contribution of decrease in free fatty acids to low triglyceride levels after diets supplemented with n-6 and n-3 polyunsaturated fatty acids. Atherosclerosis 1990; 83: 167–175
   PubMed Web of Science ®Google Scholar
• Singer P., Wirth M., Berger I., Heinrich B., Gödicke W., Voigt S., Taube C., Jaross W., Gehrisch S. Long-chain ω-3 fatty acids are the most effective polyunsaturated fatty acids for dietary prevention and treatment of cardiovascular risk factors. Nutrients in the control of metabolic diseases, A. P. Simopoulos. World Rev Nutr Diet, Karger, Basel 1992; 69: 74–112
   Google Scholar
• Sprecher H. Biochemistry of essential fatty acids. Progr Lipid Res 1981; 20: 13–22
   PubMedGoogle Scholar
• Sprecher H. Interactions between the metabolism of n-3 and n-6 fatty acids. J Intern Med 1989; 225(suppl. 1)5–10
   Google Scholar
• Stamler J., Wentforth D., Neaton J. D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823–2828
   PubMed Web of Science ®Google Scholar
• Stamler R., Grimm R. H., Jr, Dyer A. R. Cardiac status after four years in a trial on nutritional therapy for high blood pressure. Arch Intern Med 1989; 149: 661–665
   PubMedGoogle Scholar
• Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witzum J. L. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenecity. N Engl J Med 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Stout R. W. Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 1991; 90: 62S–65S
   PubMed Web of Science ®Google Scholar
• Sönnerborg A., Carlin G., Åkerlund B., Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis 1988; 20: 287–290
   PubMed Web of Science ®Google Scholar
• The international committee for the evaluation of hypertriglyce-ridemia as a vascular risk factor. The hypertriglyceridemias: Risk and management. Am J Cardiol 1991; 68: 1A–42A
   PubMed Web of Science ®Google Scholar
• Thiery J., Seidel D. Fish oil feeding results in an enhancement of cholesterol induced atherosclerosis in rabbits. Atherosclerosis 1987; 63: 53–56
   PubMed Web of Science ®Google Scholar
• Tinoco J. Dietary requirements and functions of α-linolenic acid in animals. Prog Lipid Res 1982; 21: 1–45
   PubMed Web of Science ®Google Scholar
• Thorngren M., Gustafson A. Effects of a 11-week increase in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet 1981; II: 1190–1193
   Google Scholar
• Biochemistry of lipids, lipoproteins and membranes, D. E. Vance, D. E. Vance. Elsevier. 1991
   Google Scholar
• Vessby B. n-3 fatty acids and glucose control in diabetes mellitus. J Intern Med 225, suppl. 1989; 1: 207–210
   Google Scholar
• Voss A., Reinhart M., Sankarappaa S., Sprecher H. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a Δ4-desaturase. J Biol Chem 1991; 266: 19995–20000
   PubMed Web of Science ®Google Scholar
• Wahle K. W.J., Brown J. E. Plasma lipid peroxidation and vitamin E supplementation during high intakes of fish-oil fatty acids. Fat Sci Technol 1990; 92: 326–330
   Google Scholar
• Waldhäusl W., Ratheiser K., Komjati M., Nowotny P., Pirich K., Vierhapper H. Increase of insulin sensitivity and improvement of intravenous glucose tolerance by fish oil in healthy man. Health effects of fish and fish oils, R. K. Chandra. ARTS Biomedical Publishers & Distributors, St John's, Newfoundland 1989; 171–187
   Google Scholar
• Wallin R., Saldeen T. Oxidation of n-3 fatty acids. Omega-3 fatty acids. Metabolism and biological effects. Congress abstracts. OsloNorway 1992; 119, Abstr.
   Google Scholar
• Weiner B. H., Ockene I. S., Levine P. H. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 1986; 315: 841–846
   PubMed Web of Science ®Google Scholar
• Weintraub M. S., Zechner R., Brown A., Eisenberg S., Breslow J. L. Dietary polyunsaturated fats of the omega-6 and omega-3 series reduce postprandial lipoprotein levels. J Clin Invest 1988; 82: 1884–1893
   PubMed Web of Science ®Google Scholar
• Welin L., Eriksson H., Larsson B., Swärdsudd K., Wilhelmsen L., Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology 1993; 82: 223–228
   PubMed Web of Science ®Google Scholar
• Welch W. J. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev 1992; 72: 1063–1081
   PubMed Web of Science ®Google Scholar
• WHO. Diet, nutrition, and the prevention of chronic diseases. WHO Technical Report Series No 797, Geneva 1990
   Google Scholar
• Wilhelmsen L., Swärdsudd K., Korsan-Bengtsen K., Larsson B., Welin C., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501–505
   PubMed Web of Science ®Google Scholar
• Wiman B., Hamsten A. The fibrinolytic system and its role in the etiology of thromboembolic disease. Semin Thromb Hemostas 1990; 16: 207–216
   PubMed Web of Science ®Google Scholar
• Yasugi T., Tochihara T., Fujioka T., Saito E., Kanno H., Ueno T., Matsumoto T., Takahashi Y., Watanabe H., Yamada T., Saito N. Eicosapentaenoic acid, docosahexaenoic acid and cerebral hemorrhage: EPA and DHA loading study in spontaneously hypertensive rats. Essential fatty acids and eicosanoids, A. Sinclair, R. Gibson. American Oil Chemists' Society, Champaign, Illinois 1992; 339–344
   Google Scholar